Global Immuno-Oncology Market 2020 by Company, Regions, Type and Application, Forecast to 2025

  • receipt Report ID : 99838
  • calendar_today Published On: Aug, 2020
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

Market Overview

The Immuno-Oncology market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The global Immuno-Oncology market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 14.3%% in the forecast period of 2020 to 2025 and will expected to reach USD 56950 million by 2025, from USD 33390 million in 2019.

Market segmentation

Immuno-Oncology market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Immuno-Oncology market has been segmented into:

Immune Checkpoint Inhibitors

Cytokine-Based Immunotherapy

Cancer Vaccines

CAR-T Cell Therapy

Others

By Application, Immuno-Oncology has been segmented into:

Hospitals

Drugstores

Others

Regions and Countries Level Analysis

Regional analysis is another highly comprehensive part of the research and analysis study of the global Immuno-Oncology market presented in the report. This section sheds light on the sales growth of different regional and country-level Immuno-Oncology markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Immuno-Oncology market.

The report offers in-depth assessment of the growth and other aspects of the Immuno-Oncology market in important countries (regions), including:

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Immuno-Oncology Market Share Analysis

Immuno-Oncology competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Immuno-Oncology sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Immuno-Oncology sales, revenue and market share for each player covered in this report.

The major players covered in Immuno-Oncology are:

Bristol-Myers Squibb

Gilead Sciences Inc.

AstraZeneca, Plc

Merck & Co., Inc.

Novartis

Roche AG

Dendreon Pharmaceuticals

Sanofi S.A.

Merck KGaA

Among other players domestic and global, Immuno-Oncology market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Our analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Immuno-Oncology Market Overview

1.1 Product Overview and Scope of Immuno-Oncology

1.2 Classification of Immuno-Oncology by Type

1.2.1 Global Immuno-Oncology Revenue by Type: 2015 VS 2019 VS 2025

1.2.2 Global Immuno-Oncology Revenue Market Share by Type in 2019

1.2.3 Immune Checkpoint Inhibitors

1.2.4 Cytokine-Based Immunotherapy

1.2.5 Cancer Vaccines

1.2.6 CAR-T Cell Therapy

1.2.7 Others

1.3 Global Immuno-Oncology Market by Application

1.3.1 Overview: Global Immuno-Oncology Revenue by Application: 2015 VS 2019 VS 2025

1.3.2 Hospitals

1.3.3 Drugstores

1.3.4 Others

1.4 Global Immuno-Oncology Market by Regions

1.4.1 Global Immuno-Oncology Market Size by Regions: 2015 VS 2019 VS 2025

1.4.2 Global Market Size of Immuno-Oncology (2015-2025)

1.4.3 North America (USA, Canada and Mexico) Immuno-Oncology Status and Prospect (2015-2025)

1.4.4 Europe (Germany, France, UK, Russia and Italy) Immuno-Oncology Status and Prospect (2015-2025)

1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Immuno-Oncology Status and Prospect (2015-2025)

1.4.6 South America (Brazil, Argentina, Colombia) Immuno-Oncology Status and Prospect (2015-2025)

1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Immuno-Oncology Status and Prospect (2015-2025)

2 Company Profiles

2.1 Bristol-Myers Squibb

2.1.1 Bristol-Myers Squibb Details

2.1.2 Bristol-Myers Squibb Major Business

2.1.3 Bristol-Myers Squibb SWOT Analysis

2.1.4 Bristol-Myers Squibb Product and Services

2.1.5 Bristol-Myers Squibb Immuno-Oncology Revenue, Gross Margin and Market Share (2018-2019)

2.2 Gilead Sciences Inc.

2.2.1 Gilead Sciences Inc. Details

2.2.2 Gilead Sciences Inc. Major Business

2.2.3 Gilead Sciences Inc. SWOT Analysis

2.2.4 Gilead Sciences Inc. Product and Services

2.2.5 Gilead Sciences Inc. Immuno-Oncology Revenue, Gross Margin and Market Share (2018-2019)

2.3 AstraZeneca, Plc

2.3.1 AstraZeneca, Plc Details

2.3.2 AstraZeneca, Plc Major Business

2.3.3 AstraZeneca, Plc SWOT Analysis

2.3.4 AstraZeneca, Plc Product and Services

2.3.5 AstraZeneca, Plc Immuno-Oncology Revenue, Gross Margin and Market Share (2018-2019)

2.4 Merck & Co., Inc.

2.4.1 Merck & Co., Inc. Details

2.4.2 Merck & Co., Inc. Major Business

2.4.3 Merck & Co., Inc. SWOT Analysis

2.4.4 Merck & Co., Inc. Product and Services

2.4.5 Merck & Co., Inc. Immuno-Oncology Revenue, Gross Margin and Market Share (2018-2019)

2.5 Novartis

2.5.1 Novartis Details

2.5.2 Novartis Major Business

2.5.3 Novartis SWOT Analysis

2.5.4 Novartis Product and Services

2.5.5 Novartis Immuno-Oncology Revenue, Gross Margin and Market Share (2018-2019)

2.6 Roche AG

2.6.1 Roche AG Details

2.6.2 Roche AG Major Business

2.6.3 Roche AG Product and Services

2.6.4 Roche AG Immuno-Oncology Revenue, Gross Margin and Market Share (2018-2019)

2.7 Dendreon Pharmaceuticals

2.7.1 Dendreon Pharmaceuticals Details

2.7.2 Dendreon Pharmaceuticals Major Business

2.7.3 Dendreon Pharmaceuticals Product and Services

2.7.4 Dendreon Pharmaceuticals Immuno-Oncology Revenue, Gross Margin and Market Share (2018-2019)

2.8 Sanofi S.A.

2.8.1 Sanofi S.A. Details

2.8.2 Sanofi S.A. Major Business

2.8.3 Sanofi S.A. Product and Services

2.8.4 Sanofi S.A. Immuno-Oncology Revenue, Gross Margin and Market Share (2018-2019)

2.9 Merck KGaA

2.9.1 Merck KGaA Details

2.9.2 Merck KGaA Major Business

2.9.3 Merck KGaA Product and Services

2.9.4 Merck KGaA Immuno-Oncology Revenue, Gross Margin and Market Share (2018-2019)

3 Market Competition, by Players

3.1 Global Immuno-Oncology Revenue and Share by Players (2015-2020)

3.2 Market Concentration Rate

3.2.1 Top 5 Immuno-Oncology Players Market Share

3.2.2 Top 10 Immuno-Oncology Players Market Share

3.3 Market Competition Trend

4 Market Size by Regions

4.1 Global Immuno-Oncology Revenue and Market Share by Regions

4.2 North America Immuno-Oncology Revenue and Growth Rate (2015-2020)

4.3 Europe Immuno-Oncology Revenue and Growth Rate (2015-2020)

4.4 Asia-Pacific Immuno-Oncology Revenue and Growth Rate (2015-2020)

4.5 South America Immuno-Oncology Revenue and Growth Rate (2015-2020)

4.6 Middle East & Africa Immuno-Oncology Revenue and Growth Rate (2015-2020)

5 North America Immuno-Oncology Revenue by Countries

5.1 North America Immuno-Oncology Revenue by Countries (2015-2020)

5.2 USA Immuno-Oncology Revenue and Growth Rate (2015-2020)

5.3 Canada Immuno-Oncology Revenue and Growth Rate (2015-2020)

5.4 Mexico Immuno-Oncology Revenue and Growth Rate (2015-2020)

6 Europe Immuno-Oncology Revenue by Countries

6.1 Europe Immuno-Oncology Revenue by Countries (2015-2020)

6.2 Germany Immuno-Oncology Revenue and Growth Rate (2015-2020)

6.3 UK Immuno-Oncology Revenue and Growth Rate (2015-2020)

6.4 France Immuno-Oncology Revenue and Growth Rate (2015-2020)

6.5 Russia Immuno-Oncology Revenue and Growth Rate (2015-2020)

6.6 Italy Immuno-Oncology Revenue and Growth Rate (2015-2020)

7 Asia-Pacific Immuno-Oncology Revenue by Countries

7.1 Asia-Pacific Immuno-Oncology Revenue by Countries (2015-2020)

7.2 China Immuno-Oncology Revenue and Growth Rate (2015-2020)

7.3 Japan Immuno-Oncology Revenue and Growth Rate (2015-2020)

7.4 Korea Immuno-Oncology Revenue and Growth Rate (2015-2020)

7.5 India Immuno-Oncology Revenue and Growth Rate (2015-2020)

7.6 Southeast Asia Immuno-Oncology Revenue and Growth Rate (2015-2020)

8 South America Immuno-Oncology Revenue by Countries

8.1 South America Immuno-Oncology Revenue by Countries (2015-2020)

8.2 Brazil Immuno-Oncology Revenue and Growth Rate (2015-2020)

8.3 Argentina Immuno-Oncology Revenue and Growth Rate (2015-2020)

9 Middle East & Africa Revenue Immuno-Oncology by Countries

9.1 Middle East & Africa Immuno-Oncology Revenue by Countries (2015-2020)

9.2 Saudi Arabia Immuno-Oncology Revenue and Growth Rate (2015-2020)

9.3 UAE Immuno-Oncology Revenue and Growth Rate (2015-2020)

9.4 Egypt Immuno-Oncology Revenue and Growth Rate (2015-2020)

9.5 South Africa Immuno-Oncology Revenue and Growth Rate (2015-2020)

10 Market Size Segment by Type

10.1 Global Immuno-Oncology Revenue and Market Share by Type (2015-2020)

10.2 Global Immuno-Oncology Market Forecast by Type (2019-2024)

10.3 Immune Checkpoint Inhibitors Revenue Growth Rate (2015-2025)

10.4 Cytokine-Based Immunotherapy Revenue Growth Rate (2015-2025)

10.5 Cancer Vaccines Revenue Growth Rate (2015-2025)

10.6 CAR-T Cell Therapy Revenue Growth Rate (2015-2025)

10.7 Others Revenue Growth Rate (2015-2025)

11 Global Immuno-Oncology Market Segment by Application

11.1 Global Immuno-Oncology Revenue Market Share by Application (2015-2020)

11.2 Immuno-Oncology Market Forecast by Application (2019-2024)

11.3 Hospitals Revenue Growth (2015-2020)

11.4 Drugstores Revenue Growth (2015-2020)

11.5 Others Revenue Growth (2015-2020)

12 Global Immuno-Oncology Market Size Forecast (2021-2025)

12.1 Global Immuno-Oncology Market Size Forecast (2021-2025)

12.2 Global Immuno-Oncology Market Forecast by Regions (2021-2025)

12.3 North America Immuno-Oncology Revenue Market Forecast (2021-2025)

12.4 Europe Immuno-Oncology Revenue Market Forecast (2021-2025)

12.5 Asia-Pacific Immuno-Oncology Revenue Market Forecast (2021-2025)

12.6 South America Immuno-Oncology Revenue Market Forecast (2021-2025)

12.7 Middle East & Africa Immuno-Oncology Revenue Market Forecast (2021-2025)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

14.3 Disclaimer

14.4 About US

List of Tables

Table 1. Global Immuno-Oncology Revenue (USD Million) by Type: 2015 VS 2019 VS 2025

Table 2. Breakdown of Immuno-Oncology by Company Type (Tier 1, Tier 2 and Tier 3)

Table 3. Global Immuno-Oncology Revenue (USD Million) by Application: 2015 VS 2019 VS 2025

Table 4. Global Market Immuno-Oncology Revenue (Million USD) Comparison by Regions 2015-2025

Table 5. Global Immuno-Oncology Market Size and Growth Estimation in Various Scenarios in 2020

Table 6. Bristol-Myers Squibb Corporate Information, Location and Competitors

Table 7. Bristol-Myers Squibb Immuno-Oncology Major Business

Table 8. Bristol-Myers Squibb Immuno-Oncology Total Revenue (USD Million) (2017-2018)

Table 9. Bristol-Myers Squibb SWOT Analysis

Table 10. Bristol-Myers Squibb Immuno-Oncology Product and Solutions

Table 11. Bristol-Myers Squibb Immuno-Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 12. Gilead Sciences Inc. Corporate Information, Location and Competitors

Table 13. Gilead Sciences Inc. Immuno-Oncology Major Business

Table 14. Gilead Sciences Inc. Immuno-Oncology Total Revenue (USD Million) (2018-2019)

Table 15. Gilead Sciences Inc. SWOT Analysis

Table 16. Gilead Sciences Inc. Immuno-Oncology Product and Solutions

Table 17. Gilead Sciences Inc. Immuno-Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 18. AstraZeneca, Plc Corporate Information, Location and Competitors

Table 19. AstraZeneca, Plc Immuno-Oncology Major Business

Table 20. AstraZeneca, Plc Immuno-Oncology Total Revenue (USD Million) (2017-2018)

Table 21. AstraZeneca, Plc SWOT Analysis

Table 22. AstraZeneca, Plc Immuno-Oncology Product and Solutions

Table 23. AstraZeneca, Plc Immuno-Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 24. Merck & Co., Inc. Corporate Information, Location and Competitors

Table 25. Merck & Co., Inc. Immuno-Oncology Major Business

Table 26. Merck & Co., Inc. Immuno-Oncology Total Revenue (USD Million) (2017-2018)

Table 27. Merck & Co., Inc. SWOT Analysis

Table 28. Merck & Co., Inc. Immuno-Oncology Product and Solutions

Table 29. Merck & Co., Inc. Immuno-Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 30. Novartis Corporate Information, Location and Competitors

Table 31. Novartis Immuno-Oncology Major Business

Table 32. Novartis Immuno-Oncology Total Revenue (USD Million) (2017-2018)

Table 33. Novartis SWOT Analysis

Table 34. Novartis Immuno-Oncology Product and Solutions

Table 35. Novartis Immuno-Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 36. Roche AG Corporate Information, Location and Competitors

Table 37. Roche AG Immuno-Oncology Major Business

Table 38. Roche AG Immuno-Oncology Total Revenue (USD Million) (2017-2018)

Table 39. Roche AG SWOT Analysis

Table 40. Roche AG Immuno-Oncology Product and Solutions

Table 41. Roche AG Immuno-Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 42. Dendreon Pharmaceuticals Corporate Information, Location and Competitors

Table 43. Dendreon Pharmaceuticals Immuno-Oncology Major Business

Table 44. Dendreon Pharmaceuticals Immuno-Oncology Total Revenue (USD Million) (2017-2018)

Table 45. Dendreon Pharmaceuticals SWOT Analysis

Table 46. Dendreon Pharmaceuticals Immuno-Oncology Product and Solutions

Table 47. Dendreon Pharmaceuticals Immuno-Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 48. Sanofi S.A. Corporate Information, Location and Competitors

Table 49. Sanofi S.A. Immuno-Oncology Major Business

Table 50. Sanofi S.A. Immuno-Oncology Total Revenue (USD Million) (2017-2018)

Table 51. Sanofi S.A. SWOT Analysis

Table 52. Sanofi S.A. Immuno-Oncology Product and Solutions

Table 53. Sanofi S.A. Immuno-Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 54. Merck KGaA Corporate Information, Location and Competitors

Table 55. Merck KGaA Immuno-Oncology Major Business

Table 56. Merck KGaA Immuno-Oncology Total Revenue (USD Million) (2017-2018)

Table 57. Merck KGaA SWOT Analysis

Table 58. Merck KGaA Immuno-Oncology Product and Solutions

Table 59. Merck KGaA Immuno-Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 60. Global Immuno-Oncology Revenue (Million USD) by Players (2015-2020)

Table 61. Global Immuno-Oncology Revenue Share by Players (2015-2020)

Table 62. Global Immuno-Oncology Revenue (Million USD) by Regions (2015-2020)

Table 63. Global Immuno-Oncology Revenue Market Share by Regions (2015-2020)

Table 64. North America Immuno-Oncology Revenue by Countries (2015-2020)

Table 65. North America Immuno-Oncology Revenue Market Share by Countries (2015-2020)

Table 66. Europe Immuno-Oncology Revenue (Million USD) by Countries (2015-2020)

Table 67. Asia-Pacific Immuno-Oncology Revenue (Million USD) by Countries (2015-2020)

Table 68. South America Immuno-Oncology Revenue by Countries (2015-2020)

Table 69. South America Immuno-Oncology Revenue Market Share by Countries (2015-2020)

Table 70. Middle East and Africa Immuno-Oncology Revenue (Million USD) by Countries (2015-2020)

Table 71. Middle East and Africa Immuno-Oncology Revenue Market Share by Countries (2015-2020)

Table 72. Global Immuno-Oncology Revenue (Million USD) by Type (2015-2020)

Table 73. Global Immuno-Oncology Revenue Share by Type (2015-2020)

Table 74. Global Immuno-Oncology Revenue Forecast by Type (2021-2025)

Table 75. Global Immuno-Oncology Revenue by Application (2015-2020)

Table 76. Global Immuno-Oncology Revenue Share by Application (2015-2020)

Table 77. Global Immuno-Oncology Revenue Forecast by Application (2021-2025)

Table 78. Global Immuno-Oncology Revenue (Million USD) Forecast by Regions (2021-2025)

List of Figures

Figure 1. Immuno-Oncology Picture

Figure 2. Global Immuno-Oncology Revenue Market Share by Type in 2019

Figure 3. Immune Checkpoint Inhibitors Picture

Figure 4. Cytokine-Based Immunotherapy Picture

Figure 5. Cancer Vaccines Picture

Figure 6. CAR-T Cell Therapy Picture

Figure 7. Others Picture

Figure 8. Immuno-Oncology Revenue Market Share by Application in 2019

Figure 9. Hospitals Picture

Figure 10. Drugstores Picture

Figure 11. Others Picture

Figure 12. Global Immuno-Oncology Revenue (USD Million) and Growth Rate (2015-2025)

Figure 13. North America Immuno-Oncology Revenue (Million USD) and Growth Rate (2015-2025)

Figure 14. Europe Immuno-Oncology Revenue (Million USD) and Growth Rate (2015-2025)

Figure 15. Asia-Pacific Immuno-Oncology Revenue (Million USD) and Growth Rate (2015-2025)

Figure 16. South America Immuno-Oncology Revenue (Million USD) and Growth Rate (2015-2025)

Figure 17. Middle East and Africa Immuno-Oncology Revenue (Million USD) and Growth Rate (2015-2025)

Figure 18. Global Immuno-Oncology Revenue (Million USD) and Growth Rate (2015-2025)

Figure 19. Global Immuno-Oncology Revenue Share by Players in 2019

Figure 20. Global Top 5 Players Immuno-Oncology Revenue Market Share in 2019

Figure 21. Global Top 10 Players Immuno-Oncology Revenue Market Share in 2019

Figure 22. Key Players Market Share Trend

Figure 23. Global Immuno-Oncology Revenue (Million USD) and Growth Rate (%) (2015-2020)

Figure 24. Global Immuno-Oncology Revenue Market Share by Regions (2015-2020)

Figure 25. Global Immuno-Oncology Revenue Market Share by Regions in 2018

Figure 26. North America Immuno-Oncology Revenue and Growth Rate (2015-2020)

Figure 27. Europe Immuno-Oncology Revenue and Growth Rate (2015-2020)

Figure 28. Asia-Pacific Immuno-Oncology Revenue and Growth Rate (2015-2020)

Figure 29. South America Immuno-Oncology Revenue and Growth Rate (2015-2020)

Figure 30. Middle East and Africa Immuno-Oncology Revenue and Growth Rate (2015-2020)

Figure 31. North America Immuno-Oncology Revenue Market Share by Countries (2015-2020)

Figure 32. North America Immuno-Oncology Revenue Market Share by Countries in 2019

Figure 33. USA Immuno-Oncology Revenue and Growth Rate (2015-2020)

Figure 34. Canada Immuno-Oncology Revenue and Growth Rate (2015-2020)

Figure 35. Mexico Immuno-Oncology Revenue and Growth Rate (2015-2020)

Figure 36. Europe Immuno-Oncology Revenue Market Share by Countries (2015-2020)

Figure 37. Europe Immuno-Oncology Revenue Market Share by Countries in 2019

Figure 38. Germany Immuno-Oncology Revenue and Growth Rate (2015-2020)

Figure 39. UK Immuno-Oncology Revenue and Growth Rate (2015-2020)

Figure 40. France Immuno-Oncology Revenue and Growth Rate (2015-2020)

Figure 41. Russia Immuno-Oncology Revenue and Growth Rate (2015-2020)

Figure 42. Italy Immuno-Oncology Revenue and Growth Rate (2015-2020)

Figure 43. Asia-Pacific Immuno-Oncology Revenue Market Share by Countries (2015-2020)

Figure 44. Asia-Pacific Immuno-Oncology Revenue Market Share by Countries in 2019

Figure 45. China Immuno-Oncology Revenue and Growth Rate (2015-2020)

Figure 46. Japan Immuno-Oncology Revenue and Growth Rate (2015-2020)

Figure 47. Korea Immuno-Oncology Revenue and Growth Rate (2015-2020)

Figure 48. India Immuno-Oncology Revenue and Growth Rate (2015-2020)

Figure 49. Southeast Asia Immuno-Oncology Revenue and Growth Rate (2015-2020)

Figure 50. South America Immuno-Oncology Revenue Market Share by Countries (2015-2020)

Figure 51. South America Immuno-Oncology Revenue Market Share by Countries in 2019

Figure 52. Brazil Immuno-Oncology Revenue and Growth Rate (2015-2020)

Figure 53. Argentina Immuno-Oncology Revenue and Growth Rate (2015-2020)

Figure 54. Middle East and Africa Immuno-Oncology Revenue Market Share by Countries (2015-2020)

Figure 55. Middle East and Africa Immuno-Oncology Revenue Market Share by Countries in 2019

Figure 56. Saudi Arabia Immuno-Oncology Revenue and Growth Rate (2015-2020)

Figure 57. UAE Immuno-Oncology Revenue and Growth Rate (2015-2020)

Figure 58. Egypt Immuno-Oncology Revenue and Growth Rate (2015-2020)

Figure 59. South Africa Immuno-Oncology Revenue and Growth Rate (2015-2020)

Figure 60. Global Immuno-Oncology Revenue Share by Type (2015-2020)

Figure 61. Global Immuno-Oncology Revenue Share by Type in 2019

Figure 62. Global Immuno-Oncology Market Share Forecast by Type (2021-2025)

Figure 63. Global Immune Checkpoint Inhibitors Revenue Growth Rate (2015-2020)

Figure 64. Global Cytokine-Based Immunotherapy Revenue Growth Rate (2015-2020)

Figure 65. Global Cancer Vaccines Revenue Growth Rate (2015-2020)

Figure 66. Global CAR-T Cell Therapy Revenue Growth Rate (2015-2020)

Figure 67. Global Others Revenue Growth Rate (2015-2020)

Figure 68. Global Immuno-Oncology Revenue Share by Application (2015-2020)

Figure 69. Global Immuno-Oncology Revenue Share by Application in 2019

Figure 70. Global Immuno-Oncology Market Share Forecast by Application (2021-2025)

Figure 71. Global Hospitals Revenue Growth Rate (2015-2020)

Figure 72. Global Drugstores Revenue Growth Rate (2015-2020)

Figure 73. Global Others Revenue Growth Rate (2015-2020)

Figure 74. Global Immuno-Oncology Revenue (Million USD) and Growth Rate Forecast (2021-2025)

Figure 75. Global Immuno-Oncology Revenue (Million USD) Forecast by Regions (2021-2025)

Figure 76. Global Immuno-Oncology Revenue Market Share Forecast by Regions (2021-2025)

Figure 77. North America Immuno-Oncology Revenue Market Forecast (2021-2025)

Figure 78. Europe Immuno-Oncology Revenue Market Forecast (2021-2025)

Figure 79. Asia-Pacific Immuno-Oncology Revenue Market Forecast (2021-2025)

Figure 80. South America Immuno-Oncology Revenue Market Forecast (2021-2025)

Figure 81. Middle East and Africa Immuno-Oncology Revenue Market Forecast (2021-2025)

Figure 82. Sales Channel: Direct Channel vs Indirect Channel

shopping_cart License Type

Buy Now

email Quick Contact

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketsandresearch.biz